Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. 2014

Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, 315040, Zhejiang province, China.

quinone oxidoreductase 1 (NQO1) is an important enzyme which can catalyze the two-electron reduction of quinoid compounds into hydroquinones. NQO1 Pro187Ser polymorphism can change the enzymatic activity of NQO1, and it has been proposed to be associated with risk of esophageal cancer. We performed a meta-analysis to examine the association between NQO1 Pro187Ser polymorphism and esophageal cancer. Odds ratio (OR) with a 95% confidence interval (95% CI) was used to assess the association. Twelve case-control studies with 1,725 cases with esophageal cancer and 2,341 controls were finally included in the meta-analysis. Overall, there was an obvious association between NQO1 Pro187Ser polymorphism and esophageal cancer (allele model: OR = 1.24, 95% CI 1.06-1.46, P OR = 0.009; homozygote model: OR = 1.59, 1195% CI 1.10-2.30, P OR = 0.013; dominant model: OR = 1.31, 95% CI 1.05-1.64, P OR = 0.018). In the subgroup analysis by ethnicity, there was an obvious association between NQO1 Pro187Ser polymorphism and esophageal cancer in Asians but not in Caucasians. Therefore, the meta-analysis suggests that NQO1 Pro187Ser polymorphism is associated with esophageal cancer risk.

UI MeSH Term Description Entries
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016660 NAD(P)H Dehydrogenase (Quinone) A flavoprotein that reversibly catalyzes the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. The enzyme is inhibited by dicoumarol, capsaicin, and caffeine. DT Diaphorase,Menadione Reductase,Phylloquinone Reductase,Quinone Reductase,Vitamin K Reductase,Diaphorase, DT,Reductase, Menadione,Reductase, Phylloquinone,Reductase, Quinone,Reductase, Vitamin K
D044465 White People Persons having origins in any of the white racial groups of Europe, the Middle East, or North Africa. Note that OMB category WHITE is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. European Continental Ancestry Group,White Person,Caucasian Race,Caucasoid Race,Caucasian Races,Caucasoid Races,People, White,Person, White,Race, Caucasian,Race, Caucasoid,White Peoples,White Persons
D044466 Asian People Persons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Asian Continental Ancestry Group,Asian Person,Asiatic Race,Mongoloid Race,Asian Peoples,Asian Persons,Asiatic Races,Mongoloid Races,People, Asian,Person, Asian,Race, Asiatic,Race, Mongoloid
D020022 Genetic Predisposition to Disease A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. Genetic Predisposition,Genetic Susceptibility,Predisposition, Genetic,Susceptibility, Genetic,Genetic Predispositions,Genetic Susceptibilities,Predispositions, Genetic,Susceptibilities, Genetic
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms

Related Publications

Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
March 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
January 2015, PloS one,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
March 2015, Cancer investigation,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
September 2013, British journal of cancer,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
January 2011, Breast cancer research and treatment,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
August 2012, International journal of colorectal disease,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
November 2014, British journal of cancer,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
November 2014, British journal of cancer,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
May 2014, Diagnostic pathology,
Kai Liu, and Hui Tian, and Kai-Zhong Yu, and Wei-Yu Shen, and Zhen-Chun Mao, and Chen-Hua Jin, and Hai-Bin Pan, and Jin-Xian He
November 2014, British journal of cancer,
Copied contents to your clipboard!